-+ 0.00%
-+ 0.00%
-+ 0.00%

Alzinova CEO to present at Redeye Neurology Day on Alzheimer’s vaccine, blood-based diagnostics

PUBT·10/08/2026 14:08:27
Listen to the news
Alzinova CEO to present at Redeye Neurology Day on Alzheimer’s vaccine, blood-based diagnostics
  • Alzinova will present at Redeye Neurology Day on Oct. 15, 2026, focusing on its Alzheimer’s vaccine candidate ALZ-101.
  • CEO Tord Labuda is scheduled to speak at 10:15 CEST, with an update on the planned global Phase II program.
  • The company will also outline progress in its blood-based diagnostics work using Aβ42CC technology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzinova AB published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.